Evolus Inc (EOLS)
13.41
-0.29
(-2.12%)
USD |
NASDAQ |
May 20, 12:22
Evolus Revenue (TTM): 219.70M for March 31, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 219.70M |
| December 31, 2023 | 202.08M |
| September 30, 2023 | 184.73M |
| June 30, 2023 | 168.61M |
| March 31, 2023 | 156.43M |
| December 31, 2022 | 148.62M |
| September 30, 2022 | 139.63M |
| June 30, 2022 | 132.40M |
| March 31, 2022 | 121.34M |
| Date | Value |
|---|---|
| December 31, 2021 | 99.67M |
| September 30, 2021 | 85.59M |
| June 30, 2021 | 76.58M |
| March 31, 2021 | 58.28M |
| December 31, 2020 | 56.54M |
| September 30, 2020 | 55.41M |
| June 30, 2020 | 50.92M |
| March 31, 2020 | 45.42M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
45.42M
Minimum
Mar 2020
219.70M
Maximum
Mar 2024
117.76M
Average
121.34M
Median
Mar 2022
Revenue (TTM) Benchmarks
| Viatris Inc | 15.36B |
| Shockwave Medical Inc | 787.97M |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 53.50M |
| Xtant Medical Holdings Inc | 101.23M |